Risk driven decision for high-dose therapy in multiple myeloma - No

被引：0
|
作者：
Goldschmidt, H. [1 ]
机构：
[1] Univ Klinikum Heidelberg, Med Klin, Innere Med 5, Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V800
引用
收藏
页码：242 / 242
页数：1
相关论文
共 50 条
  • [21] SEQUENTIAL HIGH-DOSE CORTICOSTEROID-THERAPY IN MULTIPLE-MYELOMA
    ARLET, P
    LAROCHE, M
    ADOUE, D
    SALLERIN, F
    VILAIN, C
    JUCHET, H
    LETALLEC, Y
    PRESSE MEDICALE, 1988, 17 (09): : 439 - 439
  • [22] HIGH-RISK MULTIPLE-MYELOMA TREATED WITH HIGH-DOSE MELPHALAN
    LOKHORST, HM
    MEUWISSEN, OJAT
    VERDONCK, LF
    DEKKER, AW
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) : 47 - 51
  • [23] ASCT and high-dose melphalan in multiple myeloma
    Sharma, Sharan Prakash
    LANCET ONCOLOGY, 2014, 15 (11): : E481 - E481
  • [24] High-dose chemotherapy in multiple myeloma - Reply
    Attal, M
    Harousseau, JL
    Bataille, R
    NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (24): : 1845 - 1845
  • [25] High-dose melphalan in patients with multiple myeloma
    Moreau, P
    Le Bonniec, M
    Harousseau, JL
    BULLETIN DU CANCER, 1999, 86 (03) : 283 - 288
  • [26] HIGH-DOSE MELPHALAN FOR MULTIPLE-MYELOMA
    CAVO, M
    BACCARANI, M
    GOBBI, M
    TURA, S
    LANCET, 1983, 2 (8360): : 1194 - 1194
  • [27] Superiority of high-dose over conventional-dose therapy for untreated multiple myeloma in the absence of high-risk cytogenetics.
    Urbauer, E
    Ackermann, J
    Noesslinger, T
    Zojer, N
    Worel, N
    Greinix, H
    Gisslinger, H
    Kaufmann, H
    Lechner, K
    Heinz, R
    Ludwig, H
    Huber, H
    Drach, J
    BLOOD, 2000, 96 (11) : 756A - 756A
  • [28] OUTCOME OF STAGE B MULTIPLE MYELOMA UNDERGOING HIGH-DOSE THERAPY WITH AUTOTRANSPLANT
    Galli, M.
    Sabadini, E.
    Remuzzi, G.
    Barbui, T.
    Rambaldi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 147 - 147
  • [29] Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
    Kulkarni, S
    Powles, RL
    Treleaven, JG
    Singhal, S
    Saso, R
    Horton, C
    Killick, S
    Tait, D
    Ramiah, V
    Mehta, J
    BONE MARROW TRANSPLANTATION, 1999, 23 (07) : 675 - 680
  • [30] Impact of previous high-dose therapy on outcome after allografting for multiple myeloma
    S Kulkarni
    R L Powles
    J G Treleaven
    S Singhal
    R Saso
    C Horton
    S Killick
    D Tait
    V Ramiah
    J Mehta
    Bone Marrow Transplantation, 1999, 23 : 675 - 680
12345